EX-4.3 7 d460243dex43.htm EX-4.3 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionThis AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is dated as of March 19, 2018, by and among Twist Bioscience Corporation, a Delaware corporation (the “Company”), Emily Leproust, Bill Peck and William Banyai (the “Founders”), the holders of outstanding Preferred Stock of the Company listed on Schedule 1 hereto (the “Existing Preferred Holders”) and the purchasers of Series D Preferred Stock of the Company listed on Schedule 2 hereto (the “New Investors,” and together with the Existing Preferred holders, the “Investors”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 17th, 2018 • Twist Bioscience Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 17th, 2018 Company Industry JurisdictionThis AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is dated as of March 19, 2018, by and among Twist Bioscience Corporation, a Delaware corporation (the “Company”), Emily Leproust, Bill Peck and William Banyai (the “Founders”), the holders of outstanding Preferred Stock of the Company listed on Schedule 1 hereto (the “Existing Preferred Holders”) and the purchasers of Series D Preferred Stock of the Company listed on Schedule 2 hereto (the “New Investors,” and together with the Existing Preferred holders, the “Investors”).